Compared to DPP-4 inhibitors, GLP-1 receptor agonists have the potential for more robust A1C reductions (0.5% to 2.0%) and weight loss
The observed increases in neurotransmitter levels with 1-MX supplementation are consistent with the mechanisms of caffeine and paraxanthine, suggesting that 1-MX may similarly enhance cognitive function by modulating key neurotransmitter systems
Citations [1] Ballard FJ, Wallace JC, Francis GL, Read LC, Tomas FM
[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Tepes M., Gojkovic S., Krezic I., Zizek H., Madzar Z., Santak G., Batelja L., Milavic M., Sikiric S., Kocman I., et al
It provides structure and offers protection for your other organ systems
This is because the medicine is still being tested